Computed tomography based analyses of body mass composition in HER2 positive metastatic breast cancer patients undergoing first line treatment with pertuzumab and trastuzumab

Body composition parameters (BCp) have been associated with outcome in different tumor types. However, their prognostic value in patients with HER2-positive metastatic breast cancer (BC) receiving first line treatment with dual anti-HER2 antibody blockade is unknown. Preclinical evidences suggest th...

Descripción completa

Detalles Bibliográficos
Autores principales: Palleschi, Michela, Prochowski Iamurri, Andrea, Scarpi, Emanuela, Mariotti, Marita, Maltoni, Roberta, Mannozzi, Francesca, Barone, Domenico, Paganelli, Giovanni, Casi, Michela, Giampalma, Emanuela, De Giorgi, Ugo, Rocca, Andrea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8888586/
https://www.ncbi.nlm.nih.gov/pubmed/35233007
http://dx.doi.org/10.1038/s41598-022-07143-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8888586/
https://www.ncbi.nlm.nih.gov/pubmed/35233007
http://dx.doi.org/10.1038/s41598-022-07143-1

Ejemplares similares